Coastal Bridge Advisors, LLC Oyster Point Pharma, Inc. Transaction History

Coastal Bridge Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$8.58 - $17.65 $62,290 - $128,138	-7,260 Reduced 37.75%	11,970 $139,000
Q4 2021 May 20, 2022	BUY	$10.17 - $18.96 $73,834 - $137,649	7,260 Added 60.65%	19,230 $356,000
Q3 2021 Nov 15, 2021	BUY	$11.67 - $18.07 $139,689 - $216,297	11,970 New	11,970 $142,000
Q3 2020 Nov 13, 2020	SELL	$17.83 - $29.12 $129,445 - $211,411	-7,260 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$27.86 - $35.93 $202,263 - $260,851	7,260 New	7,260 $210,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.